Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00688350 · ClinicalTrials.gov registry record · NA

Medication Adherence in Hypertension Study

A NA study of Hypertension, sponsored by University of Missouri-Columbia.

Completed
Registry status
NA
Development phase
15
Enrollment target
1
Study location

NCT00688350 is a NA study of Hypertension that has completed, run by University of Missouri-Columbia. The registered enrollment target is 15 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00688350, a NA study of Hypertension, has completed, sponsored by University of Missouri-Columbia.

COMPLETED
Registry status
NA
Development phase
15 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to test an intervention to help older adults do a better job of following blood pressure medication regimens prescribed by their health care providers.

Conditions Studied

Interventions

  • BEHAVIORAL Behavioral feedback

Study Locations (1)

Missouri

  • University of Missouri - Columbia

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2008-07
Est. Completion 2009-06
Phase NA

Sponsor

University of Missouri-Columbia

291 total trials

What the Registry Record Tells You About NCT00688350

The ClinicalTrials.gov registry entry for NCT00688350 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (100% lower). The listed sponsor is University of Missouri-Columbia, which has 291 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hypertension appearing as the primary indexed condition, and to 1 intervention - of which Behavioral feedback is the first listed.

NCT00688350 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.

Frequently Asked Questions

What is clinical trial NCT00688350 about?

NCT00688350 is a clinical study titled "Medication Adherence in Hypertension Study". The purpose of this study is to test an intervention to help older adults do a better job of following blood pressure medication regimens prescribed by their health care providers.

What is the current status of trial NCT00688350?

This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2008-07. Estimated completion is 2009-06.

What conditions does trial NCT00688350 study?

This clinical trial studies the following conditions: Hypertension.

What interventions are being tested in trial NCT00688350?

The interventions under investigation include: Behavioral feedback (BEHAVIORAL).

Who is sponsoring clinical trial NCT00688350?

This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00688350 being conducted?

This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.